t
| TIDM | IBT |
| Share Price | 1,067.50p-2.76% |
| Market Cap | £441.77m |
The Board of International Biotechnology Trust plc announced its unaudited net asset values per share on 11 February 2022. As of Thursday 10 February, the ex income NAV per share was 669.69 Pence and the cum income NAV per share was 666.21 Pence. This categorisation follows the AIC guidance note issued on 3 July 2007.
| Date | 11 Feb 2022 |
| Time | 11:42:38 |
| Category | Corporate updates |
| ID | 4619B |
International Biotechnology Trust plc
Net Asset Values
The Board of International Biotechnology Trust plc announces that the unaudited net asset value per share
|
Date |
NAV |
Pence |
|
Thursday 10 Feb |
Ex Income |
669.69 |
|
Thursday 10 Feb |
Cum Income |
666.21 |
The above disclosure on NAV categorisation is as per the AIC guidance note "NAVs published via Regulatory Information Service (RIS) Platforms" issued 3 July 2007
11-Feb-2022
Enquiries:
International Biotechnology Trust plc
James Costine
SV Health Managers LLP
020 7421 7070